TS1215561855	treatedDisease 81 128	community-acquired respiratory tract infections
TS1515561855	treatedDisease 267 314	community-acquired respiratory tract infections
TS115561855	sideeffect 429 444	adverse effects
TS1315561855	sideeffect 542 552	pneumoniae
TS3115561855	drug 573 595	Haemophilus influenzae
TS3415561855	treatedDisease 806 834	community-acquired pneumonia
TS3315561855	treatedDisease 837 877	acute exacerbation of chronic bronchitis
TS515561855	treatedDisease 884 893	sinusitis
TS1915561855	food3 1300 1307	protein
TS415561855	sideeffect 1832 1839	obesity
TS2815561855	drug 1865 1880	pseudoephedrine
TS3215561855	sideeffect 2330 2340	pneumoniae
TS2915561855	sideeffect 2398 2408	influenzae
TS2515561855	treatedDisease 3286 3333	community-acquired respiratory tract infections
T1	drug 52 63	garenoxacin
T2	drug 131 142	Garenoxacin
T3	drug 214 223	quinolone
R1	treat Arg1:T3 Arg2:TS1515561855	
T4	drugEffect 456 478	antimicrobial activity
T5	drug 715 726	garenoxacin
T6	dosage 750 756	400 mg
T7	frequency 757 767	once daily
T8	duration 768 784	for 5 to 10 days
T9	modeadm 740 746	orally
T10	drug 2209 2220	garenoxacin
T11	drug 2705 2716	Garenoxacin
T12	drug 2806 2817	garenoxacin
T13	sideeffect 2883 2900	renal dysfunction
T14	dosage 3190 3196	400 mg
T15	drug 3053 3064	Garenoxacin
T16	drugEffect 3149 3171	antimicrobial activity
R2	has_effect Arg1:T15 Arg2:T16	
T17	drug 3200 3211	garenoxacin
T18	frequency 3212 3222	once daily
